NeuroFlow Closes $7.5M Series A
2019-12-16
PHILADELPHIA, PA, NeuroFlow announces a $7.5 million Series A financing round led by San Francisco-based Builders VC.
NeuroFlow is a platform for getting patients with behavioral health issues better by supporting clinical teams with collaborative and measurement-based tools in all care settings. The company announces a $7.5 million Series A financing round led by San Francisco-based Builders VC. Also participating in the round are Dreamit Ventures, Spring Point Partners, Red & Blue Ventures, and AWT Private Investments. NeuroFlow will use the funds to support the expansion of its team and further invest in product integrations and data science to continue building its comprehensive behavioral health and collaborative care platform.
"What started as a response to a personal connection to the mental health crisis has become a mission driven business partnering with hundreds of providers to support the overall health of tens of thousands of individuals," said NeuroFlow CEO and Co-Founder Chris Molaro. "We're helping patients get better, faster and improving the way care is managed. Partnering with Builders VC aligns us with a team of industry experts who understand both the challenges and opportunities in transforming the way behavioral health is addressed and treated."
Builders VC, a leading venture capital firm with investments in several health tech companies, saw value in NeuroFlow's technology and the market demand for new solutions closing the divide between mental and physical health. The deal was led by Builders VC partner Mark H Goldstein, who is also the Chairman of the UCSF HealthHub.
"In the sea of mental health solutions, NeuroFlow stood out to us as being the one that was most 'clinical grade'," remarked Goldstein. "They had the only solution we found that effectively connects providers and care teams to the right information and mental health resources to make their care more effective."
Existing electronic health record integrations, risk stratification capabilities, and natural language processing are just some of the features that clinical customers, including premier health systems like Jefferson Health, use to maximize care management efficiency and scale in order to decrease costs of care and improve outcomes. By aggregating data and building comprehensive patient profiles, care teams can identify patterns to inform key treatment decisions. NeuroFlow has approximately 25,000 patients on its platform, and has been implemented at more than 200 healthcare facilities across the country.
About NeuroFlow
NeuroFlow is a collaborative and measurement-based behavioral health platform integrated in all care settings. NeuroFlow's suite of HIPAA-compliant, cloud-based tools simplify remote patient monitoring, improve risk stratification, and facilitate collaborative care. Hundreds of health systems, clinicians, and care teams are using NeuroFlow to bridge the gap between mental and physical health in order to improve patient outcomes and reduce the cost of care. Learn more at http://www.neuroflowsolution.com
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors